Disclosure Of Fair Value Measurement [Text Block]

Sopharma Trading AD - Filing #6022492

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
582,859,000.000 BGN
616,529,000.000 BGN
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
497,959,000.000 BGN
539,591,000.000 BGN
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
24,912,000.000 BGN
25,773,000.000 BGN
225,000.000 BGN
50,463,000.000 BGN
84,900,000.000 BGN
797,000.000 BGN
34,276,000.000 BGN
789,000.000 BGN
34,276,000.000 BGN
76,938,000.000 BGN
10,723,000.000 BGN
29,609,000.000 BGN
22,595,000.000 BGN
392,000.000 BGN
76,938,000.000 BGN
34,276,000.000 BGN
2,038,000.000 BGN
21,806,000.000 BGN
75,804,000.000 BGN
20,585,000.000 BGN
395,000.000 BGN
780,000.000 BGN
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.